SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing increased volatility as investors closely monitor the upcoming finalization of Medicare Advantage and Part D payment rates for 2027. While some market participants are concerned about potential regulatory headwinds and sector-wide insurance challenges, the community is actively debating whether current price levels represent a significant value-buying opportunity or a risk of further downside.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is generating intense debate as investors weigh the stock's significant growth and potential relisting catalysts against volatility and concerns regarding majority shareholder control. The community is actively discussing recent insider filings, the strategic implications of the Blue Bottle acquisition, and the potential for a rebound as China's coffee consumption expands.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is currently seeing intense community debate as the stock navigates a volatile period near all-time lows, with investors weighing the potential for a technical bounce against concerns over production scaling and manufacturing yield hurdles. While some market participants remain focused on the long-term potential of the company's silicon-anode battery technology and upcoming product milestones, others are actively trading based on short-term sentiment, skepticism over management's execution, and high short interest.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana is seeing high volatility and intense community debate following CMS's final 2027 Medicare Advantage payment rate announcement, with investors closely watching for signs of stability after significant recent selling pressure. The community is actively weighing the potential impact of these rates on operational margins against the stock's currently discounted valuation, leading to a split between those looking to accumulate for a potential recovery and others wary of further downside risk.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently experiencing intense market volatility, driven by a blend of speculative short-squeeze activity and skepticism regarding its fundamental financial health, including high debt levels and negative free cash flow. While the stock has seen aggressive price swings and heavy institutional interest, the community remains sharply divided, with bulls pointing to potential recovery catalysts and bears warning that current price levels are disconnected from the company's long-term operational challenges.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is drawing significant attention as investors speculate on a potential buyout or leadership change, with high short interest fueling debates over whether the stock is an oversold dividend play or a value trap. While some market participants are banking on institutional accumulation and turnaround potential, others remain skeptical, pointing to sluggish foot traffic and the ongoing search for a permanent CEO.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing a surge in investor attention as the community anticipates major contract announcements linked to the company's role as a critical gatekeeper in AI chip reliability. Investors are actively discussing the potential for a rerating as the firm pivots toward hyperscale data center infrastructure, though some remain cautious due to historical earnings volatility and high expectations ahead of upcoming financial reports.

Mega Fortune Co., Ltd. operates as a holding company which provides information technology services. It specializes in delivering comprehensive IoT solutions and services across various industries. The firm offers low carbon property management, energy, stock and GreenTech management services. The company was founded in 2011 and is headquartered in Hong Kong.

Mega Fortune Co Ltd.

Mega Fortune Company Limited

Mega Fortune is seeing heightened volatility as traders speculate on a potential short squeeze, with community discussion heavily divided between those hunting for a massive 'HK-style' IPO runner and those dismissing it as a typical low-float pump and dump. The stock remains a focal point for momentum players monitoring high relative volume and frequent halts, while many community members warn of the risks associated with the stock's thin float and history of aggressive price swings.

Target Corp. engages in the operation and ownership of general merchandise stores. It offers food and general merchandise, clothing and household goods, electronics, and toys. Its brands include A New Day, All in Motion, Art Class, Auden, AVA & VIV, Boots and Barkley, Brightroom, Bullseye's Playground, Casaluna, Cat & Jack, Cloud Island, Colsie, dealworthy, Embark, Everspring, Favorite Day, Figmint, Future Collective, Gigglescape, Good & Gather, Goodfellow & Co, Hearth & Hand with Magnolia, Heyday, Hyde & EEK! Boutique, JoyLab, Kindfull, Kona Sol, Made By Design, Market Pantry, Mondo Llama, More Than Magic, Opalhouse, Open Story, Original Use, Pillowfort, Project 62, Room Essentials, Shade & Shore, Smartly, Smith & Hawken, Sonia Kashuk, Spritz, Sun Squad, Threshold, Universal Thread, up&up, Wild Fable, Wondershop, Xhilaration, California Roots, Casa Cantina, The Collection, Headliner, Jingle & Mingle, Rosé Bae, Photograph, SunPop, and Wine Cube. The company was founded by George Draper Dayton in 1902 and is headquartered in Minneapolis, MN.

Target Corp

Target is gaining momentum as investors react to a strategic leadership shakeup and a refocus on store staffing, while community sentiment remains divided between those betting on a value-driven turnaround and critics concerned about ongoing political headwinds and consumer spending shifts.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is experiencing intense community focus and volatility ahead of its earnings report, with sentiment split between speculative optimism over its ICHRA platform and 2026 profitability guidance and bearish concerns regarding membership retention and high medical loss ratios. Investors are closely watching for any potential margin recovery or institutional positioning as the stock trades near multi-year support levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>IMUX shares have consistently traded above $1 since February 27.</li><li>The company appointed Jon Congleton, CEO of Mineralys Therapeutics, to its board of directors on Tuesday.</li><li>It recently closed a private placement of up to $400 million to support late-stage trials for the treatment of multiple sclerosis.</li></ul>Shares of Immunic, Inc (IMUX) gained around 7% on Wednesday after the company said it had regained compliance with Nasdaq’s listing rules on March 26.The firm regained compliance after the stock closed at or above $1 for at least 20 consecutive business days. The update removes concerns about a potential delisting from the Nasdaq Capital Market.<a href="https://stocktwits.com/symbol/IMUX">IMUX shares</a> have consistently&nbsp;traded above $1 since February 27.On Tuesday, the company appointed Jon Congleton, CEO of Mineralys Therapeutics, to its board of directors.&nbsp;<h2 class="st-heading-2">Immunic Secures Patent And Raises $400 Million</h2>Last month, the European Patent Office granted Immunic a key patent covering dosing regimens for its lead drug, Vidofludimus Calcium, to treat patients with&nbsp;multiple sclerosis. The protection is expected to last until 2038, with a potential extension to 2043.&nbsp;The patent broadly covers multiple forms of the drug, ensuring strong exclusivity across Europe and building on earlier approval from the United States Patent and Trademark Office.The company also closed a private placement of up to $400 million, led by BVF Partners. Immunic secured $200 million upfront, with additional funding tied to future warrants. The company said the funds will support late-stage trials for multiple sclerosis, aimed at helping slow disease progression.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits remained in the ‘bearish’ zone over the past 24 hours.One user highlighted the potential for a reverse share split.<stembedurl>https://stocktwits.com/ccledez/message/649165039</stembedurl>Another user was bullish about Congleton’s appointment.<stembedurl>https://stocktwits.com/Mvvh1987/message/649022575</stembedurl>Year-to-date, the stock has gained more than 113%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

IMUX Stock Jumps 6% Pre-Market Today – Here’s The Latest Update On Its Compliance With Nasdaq Listing Rules 

Shares of Immunic, Inc (IMUX) gained around 6% in pre-market trading on Wednesday after the company said it had regained compliance with Nasdaq’s listing rules on March 26.

Equity

The company regained compliance after the stock closed at or above $1 for at least 20 consecutive business days.

Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement

Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire NEW YORK, April 1, 2026 NEW YORK, April 1, 2026 /PRNewswire/ -- Immunic, Inc.(Nasdaq: IMUX),a late-stage biotechnology company pioneering the...

Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton

Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton Immunic Strengthens Its Board of Directors with the Appointment of Seasoned...

Immunic (NASDAQ:IMUX) Earns Buy Rating from Analysts at Guggenheim

Guggenheim initiated coverage on shares of Immunic in a research report on Tuesday. They issued a "buy" rating and a $7.00 price objective for the company...

Immunic, Inc. (NASDAQ:IMUX) Given Average Recommendation of "Buy" by Brokerages

Immunic, Inc. (NASDAQ:IMUX - Get Free Report) has been assigned an average rating of "Buy" from the eight ratings firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have given a buy recommendation and...

Immunic Conference: Transformative 2026 Ahead With Pivotal MS Data Due Late Year, NDA Next

Immunic (NASDAQ:IMUX) executives outlined what they described as a transformative 2026, with pivotal data expected late in the year for the company's lead multiple sclerosis (MS) candidate...

Immunic Details Vidofludimus Calcium MS Strategy, Phase III Timeline at Leerink Conference

Immunic (NASDAQ:IMUX) executives outlined their multiple sclerosis (MS) development strategy and commercial thinking for vidofludimus calcium during a session at the Leerink Partners Global...

Short Interest in Immunic, Inc. (NASDAQ:IMUX) Rises By 14.5%

Immunic, Inc. (NASDAQ:IMUX - Get Free Report) saw a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 7,579,660 shares, a growth of...

Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium

Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for...

Immunic to Participate in Investor Conferences in March

Immunic to Participate in Investor Conferences in March Immunic to Participate in Investor Conferences in March PR Newswire NEW YORK, March 3, 2026 NEW YORK, March 3, 2026 /PRNewswire/ -- Immunic...

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on multiple sclerosis, celiac disease and other neurologic and gastrointestinal disorders. The firm's products include IMU-838, IMU-856, and IMU-381. The company was founded in 2016 and is headquartered in New York, NY.

IMUX
Immunic Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IMUX News

IMUXImmunic Inc